AN2 Therapeutics Inc (ANTX)
2.56
+0.02
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
2.55
-0.01
(-0.39%)
After-Hours: 20:00
AN2 Therapeutics Price: 2.56 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 03, 2024 | 2.56 | 2.67 | 2.50 | 2.56 | 168259.0 |
May 02, 2024 | 2.42 | 2.57 | 2.410 | 2.54 | 82302.00 |
May 01, 2024 | 2.40 | 2.49 | 2.377 | 2.40 | 58105.00 |
Apr 30, 2024 | 2.39 | 2.445 | 2.36 | 2.40 | 91402.00 |
Apr 29, 2024 | 2.34 | 2.44 | 2.34 | 2.37 | 67621.00 |
Apr 26, 2024 | 2.30 | 2.37 | 2.20 | 2.32 | 121380.0 |
Apr 25, 2024 | 2.39 | 2.40 | 2.28 | 2.28 | 178962.0 |
Apr 24, 2024 | 2.39 | 2.44 | 2.39 | 2.40 | 44748.00 |
Apr 23, 2024 | 2.36 | 2.42 | 2.31 | 2.37 | 83086.00 |
Apr 22, 2024 | 2.49 | 2.496 | 2.36 | 2.36 | 116269.0 |
Apr 19, 2024 | 2.48 | 2.48 | 2.40 | 2.47 | 101636.0 |
Apr 18, 2024 | 2.48 | 2.52 | 2.36 | 2.38 | 145364.0 |
Apr 17, 2024 | 2.48 | 2.508 | 2.43 | 2.48 | 87478.00 |
Apr 16, 2024 | 2.51 | 2.55 | 2.43 | 2.47 | 72705.00 |
Apr 15, 2024 | 2.74 | 2.74 | 2.50 | 2.50 | 192659.0 |
Apr 12, 2024 | 2.98 | 3.00 | 2.73 | 2.74 | 351652.0 |
Apr 11, 2024 | 3.05 | 3.115 | 2.96 | 3.00 | 288537.0 |
Apr 10, 2024 | 3.00 | 3.185 | 2.90 | 3.04 | 1.673M |
Apr 09, 2024 | 3.01 | 3.17 | 2.95 | 3.05 | 396979.0 |
Apr 08, 2024 | 3.10 | 3.10 | 2.995 | 3.01 | 296902.0 |
Apr 05, 2024 | 3.23 | 3.285 | 2.98 | 3.01 | 530085.0 |
Apr 04, 2024 | 3.39 | 3.535 | 3.24 | 3.25 | 199839.0 |
Apr 03, 2024 | 3.41 | 3.49 | 3.27 | 3.37 | 253732.0 |
Apr 02, 2024 | 3.76 | 3.88 | 3.39 | 3.40 | 525180.0 |
Apr 01, 2024 | 3.41 | 3.80 | 3.36 | 3.76 | 645589.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.28
Minimum
Apr 25 2024
22.29
Maximum
Aug 15 2022
11.55
Average
10.52
Median
Price Benchmarks
Gilead Sciences Inc | 64.78 |
QuidelOrtho Corp | 42.50 |
CymaBay Therapeutics Inc (DELISTED) | 32.48 |
Insmed Inc | 25.55 |
Revance Therapeutics Inc | 3.95 |
Price Related Metrics
Price to Book Value | 0.6124 |
Earnings Yield | -110.2% |
Market Cap | 76.36M |